Full-Service Global Support for COVID-19 Studies

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.
Full-Service Global Support for COVID-19 Studies

Related Resources

Video

Cultural Competence in Clinical Research

Brochure

Vaccine Development

Webinar

Africa’s Potential for Clinical Research

Video

Global Vaccine Development

Indication Overview

Our Clinical Trial Experience With Malaria

Brochure

Our Experience in sub-Saharan Africa

Webinar

Follow the Epi: Finding TB-Prevalent Populations to Guide TB Vaccine Protocol Design

Video

Purpose of the Visit to the PREVAIL Network in Liberia